• FirefoxInstall the new Firefox »
  •  Dow Up1.49% Nasdaq Up1.15%

    More On LUPIN.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Lupin Limited (LUPIN.NS)

    -NSE
    2,008.40 Up 9.40(0.47%) 6:00AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Lupin Limited
    Laxmi Towers, B Wing
    Bandra Kurla Complex
    Mumbai, 400051
    India - Map
    Phone: 91 22 6640 2222
    Fax: 91 22 6640 2130
    Website: http://www.lupinworld.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drugs - Generic
    Full Time Employees:15,000

    Business Summary 

    Lupin Limited, a pharmaceutical company, produces, develops, and markets a range of branded and generic formulations and active pharmaceutical ingredients (APIs) primarily in India, the United States, and Japan. It offers various formulations for use in the areas of cephalosporin, cardiovascular (CVS), central nervous system (CNS), anti-asthma, anti-tuberculosis, diabetology, dermatology, gastro intestinal, and other therapy segments; and APIs for use in therapeutic areas of antibiotics, anti-tuberculosis, CVS, CNS, analgesics, and anti-gout. The company also develops and out-licenses its drug delivery technologies and platforms; and creates and develops biosimilars for various therapeutic indications, such as oncology, inflammation, antivirals, osteoporosis, and rheumatoid arthritis. In addition, it is engaged in the novel drug discovery and development programs for use in the treatment of metabolic disorders, pain and inflammation, autoimmune diseases, CNS disorders, cancer, and infectious diseases. Lupin Limited has strategic development and licensing agreement with Celon Pharma S.A. to develop fluticasone/salmeterol dry powder inhaler product that is a generic version of GlaxoSmithKlineÂ’s Advair Diskus; and strategic partnership with Merck Serono S.A. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Lupin Limited

    Key Executives 
     PayExercised
    Dr. Desh Bandhu Gupta ,
    Founder, Chairman, Member of Share Transfer Committee and Member of Allotment Committee
    371.53MN/A
    Mrs. Vinita Gupta , 47
    Chief Exec. Officer and Exec. Director
    40.00KN/A
    Mrs. Manju D. Gupta , 71
    Exec. Director, Member of Share Transfer Committee and Member of Allotment Committee
    5.18MN/A
    Mr. Nilesh D. Gupta ,
    Managing Director and Exec. Director
    60.67MN/A
    Mr. Ramesh Swaminathan ,
    Chief Financial Officer
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in INR.